AzTrials
AzTrials

Energy Supply; DeficiencyNCT05203133

Effects of Acute Energy Deficit and Aerobic Exercise on Muscle Quality

A study testing Energy Balance, Energy Deficit and Baseline Assessment in people with Energy Supply; Deficiency and Energy Balance, run by Liverpool John Moores University at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

10 healthy, male, participants will complete a a 5-day baseline assessment (days -5 to -1) and two consecutive 5-day periods of controlled exercise to increase oxidative capacity (3 days of aerobic exercise per period, 15 kcal/kg FFM/day energy expenditure cycling) and energy intake (15 days in total, with a testing… Read more about this study

Who is it for?
Ages 18 to 40 years, men onlyHealthy volunteers can take part
What is being tested?
Energy Balance, Energy Deficit and Baseline Assessment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteUnited Kingdom
Study dates
23 Aug 2021to 15 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Gender/Sex - Male
  • Age - 18 - 40
  • % body fat - ~18 - 26 %
  • Health - Healthy (as determined by pre-participation questionnaires)
  • Training Status - Regularly Exercising/Aerobically trained (3-4 aerobic training sessions/week, 3-5 hrs/week) Non-smokers
  • Weight-stable (within 2 kg) for the past 6-months

Who cannot join

  • Gender/Sex - Female/Other
  • Age - <18 - >40
  • Health - Deemed unable to perform exercise (assessed via readiness to exercise questionnaire)
  • Current smoker.
  • Medical Condition - Those with any previous diagnosis of; Osteoporosis/low bone mineral density, cardio-vascular disease, Diabetes Mellitus, Cerebrovascular Disease, blood-related illness/disorder, Asthma or other respiratory illness/disorder, Liver Disease, Kidney Disease, gastrointestinal disease, Eating Disorder or Disordered Eating.
  • Those currently taking prescription medication or unwell with a cold or virus at the time of participation.
Show all 10Show fewer
  • Those unwilling to adhere to the study's methodological requirements (including adhering to alterations in diet and training - inc. alcohol abstention) from the day prior to intervention onset (24 hrs pre-intervention) to completion of follow-up assessments (day-11).
  • Those following a restrictive diet (e.g. vegetarians/vegans)
  • Any individuals with a food allergy/intolerance
  • Training status - Does not train aerobically 3 + times/week (over past 6 months on average)

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Liverpool John Moores University

    Liverpool, Merseyside, L3 3AF

Other trials in United Kingdom

About this study

Official title: Investigating the Combined Effect of Acute Energy Deficit and Aerobic Exercise Training on Muscle Quality in Healthy Adult Males

10 healthy, male, participants will complete a a 5-day baseline assessment (days -5 to -1) and two consecutive 5-day periods of controlled exercise to increase oxidative capacity (3 days of aerobic exercise per period, 15 kcal/kg FFM/day energy expenditure cycling) and energy intake (15 days in total, with a testing session on morning 16). This will achieve states of energy balance (EB; energy availability - EA - 45 kcal/kg of fat free mass (FFM)/day), required for weight maintenance (days 1 - 5), followed by energy deficit (ED; EA 10 kcal/kg FFM/day), required for weight loss on days 6 - 10.

Over the data-collection period, participants will consume deuterium (D2O) tracer to facilitate dynamic proteomic profiling to assess the impact of the intervention on muscle quality (primary outcome measure). Muscle biopsies will therefore be collected on days -5, 1, 6 \& 11, alongside daily saliva samples, and venous blood collection on days -5, 1, 3, 5, 6, 8, 10 \& 11. These samples will be used to assess further, secondary, outcome measures including alterations in intra-muscular lipid profiles (lipid droplet content, morphology and lipid-droplet associated proteins in different subcellular compartments [intermyofibrillar vs subsarcolemmal]), alterations in blood metabolites and hormones and skeletal muscle glycogen concentrations. Changes in body mass, body composition and RMR will also be assessed.

Read the detailed description

Justification for the research:

Weight-loss strategies that use energy restriction alone can lead to impaired muscle mass, which can also further impair health of individuals with metabolic conditions, such as type 2 diabetics. Skeletal muscle mass and function are key to maintaining a healthy metabolism and quality of life throughout the lifespan. The combination of exercise and calorie restriction is a powerful intervention for reducing body weight and improving the metabolism and health status of healthy, overweight and obese individuals. The investigators have previously shown that skeletal muscle protein synthesis is reduced with energy restriction and that resistance-type exercise can reverse this negative effect. Aerobic-type exercise also has the capacity to stimulate muscle protein synthesis and improve the quality of muscle by increasing mitochondrial protein synthesis. Nonetheless, how energy deficit overlayed on top of aerobic exercise modulates skeletal muscle quality is not well characterised. Furthermore, existing studies have looked only into mixed (unspecific) protein synthesis of different intracellular compartments without providing details on how protein synthesis for specific proteins is regulated.

This project will provide novel data to unravel the mechanisms behind the positive effect of energy restriction and concomitant aerobic exercise on skeletal muscle quality.

Aerobic exercise alone is a well-established intervention to increase mitochondrial capacity and skeletal muscle function, but the effect on skeletal muscle of overlaying energy restriction while performing aerobic exercise is not well characterised. Recent findings in Rhesus monkeys, whose physiology responds in a very similar way to that of humans, has shown that life-long caloric restriction has a profound positive effect on skeletal muscle. These findings show that caloric restriction not only maintains contractile content of muscle, but also rescues the age-related decline of skeletal muscle mitochondrial content and capacity. However, physical activity in this study was not controlled and appeared to be higher in the caloric restriction group, representing an important confounding factor. Research in humans addressing similar questions so far has been less clear. Pronounced weight loss through energy restriction alone (10% total body weight in ~7.5 wk) in obese women lead to a decrease in muscle mitochondrial content. In stark contrast, using a milder restriction of 25% of total energy alone or combined with exercise during 6 months in overweight individuals showed increased expression of genes encoding mitochondrial proteins in both groups. However, despite these promising findings suggesting that weight-loss combined with exercise will enhance skeletal muscle metabolism, there are currently no strong data to provide support on the use of concomitant energy restriction and aerobic exercise with in-depth analysis of its physiological and molecular effects in humans.

The proposed study herein will include a short period of tightly controlled exercise and dietary intake to show that energy deficit while performing aerobic exercise results in further benefits to muscle metabolic adaptation. The current project builds on from the investigator's previous and recent research findings to directly address this question. This research has shown that resistance exercise during 30% daily energy deficit rescues the decrease in mixed (unspecific) myofibrillar protein synthesis observed with energy deficit alone. Moreover, the investigator's research has shown that aerobic exercise up-regulates specific proteins in skeletal muscle mitochondria in rodents; that skeletal muscle lipid droplet profile is responsive to exercise and nutrition; that nutrition modulates the cellular response to aerobic exercise and, importantly; that aerobic exercise after short-term (~14 hours) energy deficit can up-regulate markers of mitochondrial biogenesis in skeletal muscle and improve metabolic control in humans.

Objectives \& Hypothesis:

The primary research question associated with this study is: 'What is the combined effect of an energy deficit and aerobic exercise training on muscle quality (synthesis rates of individual, sarcoplasmic and mitochondrial proteins) and intramuscular lipid dynamics over a five-day period in healthy males?'

Further objectives:

  1. Identify the mechanisms by which a short-term energy deficit (achieved through concomitant energy restriction and exercise) can regulate individual muscle protein turnover (synthesis, breakdown and abundance), intramuscular lipid dynamics, metabolites and muscle glycogen content during weight-loss.
  2. Provide novel evidence for the capacity of a potato-based diet as an effective source of nutrients to promote positive skeletal muscle and metabolic adaptations during weight loss.

Study hypothesis:

Short-term energy restriction with concomitant aerobic exercise will increase the quality and quantity of skeletal muscle proteins related to mitochondrial capacity, improve skeletal muscle intracellular lipid droplet profile and modulate blood-borne markers of metabolic health compared to exercise without energy deficit.

Study Methods:

Participants will first undertake testing for characterisation (detailed below) followed by a 5-day baseline assessment (days -5 to -1) and two consecutive 5-day periods of controlled exercise to increase oxidative capacity (3 days of aerobic exercise per period, 15 kcal/kg FFM/day energy expenditure running) and energy intake (15 days in total, with a testing session on morning 16). This will achieve states of energy balance (EB; energy availability - EA - 45 kcal/kg of fat free mass (FFM)/day), required for weight maintenance (days 1 - 5), followed by energy deficit (ED; EA 10 kcal/kg FFM/day), required for weight loss on days 6 - 10. This experimental design, as well as energy intake and expenditure, replicates what the investigators have previously used to successfully determine other physiological effects of ED on skeletal muscle. Five days of EB and EA will allow for tight control of dietary intake and will be sufficient to detect changes in the main parameters being investigated.

Participant characterisation testing will be ~15 days prior to the start of baseline assessment to determine compliance with inclusion criteria, fitness levels (maximal oxygen consumption and lactate threshold [via finger-prick capillary samples]) and body composition. At baseline assessment a resting muscle a biopsy will be taken from the vastus lateralis (quadriceps), prior to ingestion of the tracer deuterium oxide (D2O) through the following 15 days to allow dynamic proteomic profiling of skeletal muscle. A total of 4 biopsies will be taken per participant, which is in line with the investigator's prior research. The baseline assessment is used for enrichment of D2O for dynamic proteomic profiling assay and ensuring regular physical activity of individuals matches requirements of the study. Throughout each 5-day experimental period, muscle biopsies (days -5, 1, 6 \& 11), daily saliva samples (non-stimulated, collected at home) and regular venous blood samples (days -5, 1, 3, 5, 6, 8, 10 \& 11) will be collected for the assessment of dynamic proteomic profiling, fibre-type specific lipid droplet profiling, skeletal muscle glycogen and D2O, and blood-borne hormones and metabolites related to weight loss. Resting Metabolic Rate (RMR; assessed via indirect calorimetry) and body composition assessment will be conducted using dual X-ray absorptiometry (DXA) scans on days -5, 1, 6 \& 11 of the intervention. Bioelectrical impedance analysis (BIA) will also be used to assess body composition at each lab visit (days -5, 1, 3, 5, 6, 8, 10 \& 11).

Dietary interventions and energy balance:

The diet will follow the reference daily intake of nutrients to provide ~60, 20 and 20% of energy from carbohydrates, fat and protein, respectively. In line with funding requirements, the percentage of total energy from potato-based sources will be >60% during EB and >65% during ED. Potatoes will be cooked in a range of different ways that do not add significant amount of energy such as boiled, microwaved, baked, etc.

Energy availability manipulation:

Energy availability (EA), which is defined as energy intake minus energy expenditure from exercise - normalised to fat free mass - is used as a key parameter to determine energy balance. The investigators are the first to have shown that values under 30 kcal/kg/FFM can modulate skeletal muscle responses, which is in line with other research on a range of metabolic responses to EA. Based on this recent research, which used 20 kcal/kg FFM/day for ~14 hs, the current intervention will induce a more pronounced energy deficit for longer. The average energy intake across the 5 days for an average 85 kg (70 kg FFM) participant will be 3780 kcal/day for EB and 1330 kcal/day ED. This will achieve an approximate cumulative energy deficit of 12250 kcal over the 5-day period resulting in approximately ~1.5 kg of body mass loss from net tissue, given that ~7450 kcal are necessary to lose 1 kg of net tissue. Water loss will account for an additional ~1 kg of the loss in body weight which will be a consequence of a decrease in endogenous carbohydrate (glycogen) stores, to which water binds, as well water fluctuation due to sodium changes. Skeletal muscle glycogen is also a regulator of the muscle qualitative aspects and will also be investigated.

Subjects. A normal population will allow the researchers to determine the physiological responses to this intervention. Ten young (18-40 years) healthy, regularly exercising men with a body fat percentage ~18-26%.

Quality:

The researcher's associated with this study and associated with the review of the study protocol are all members of staff (or a PhD Student) within the Liverpool John Moores University Research Institute for Sport \& Exercise Sciences (RISES). In the 2014 RISES (LJMU) submitted 34.75 FTE (full time equivalent) to Unit of Assessment 26 (UoA26) and attained a GPA (Grade Point Average) of 3.57. Placed second on GPA in the UoA, RISES became the leading centre for Sport and Exercise Science Research Quality in the UK (4* - 61% of all activity world leading, 3* - 36% of all activity internationally excellent standard). RISES submitted the largest volume of 4* outputs (n=60) in the UoA, had 90% of the impact activity rated at 4* and had 100% of the environment rated as 4*. Importantly, out of 1,911 submissions in all 36 UoA's RISES came 11th in the entire UK for GPA achieved at REF2014 putting RISES (LJMU) amongst Oxford, UCL, LSE and Cambridge in the league tables for this metric.

Being tested
Energy Balance, Energy Deficit, Baseline Assessment
Keywords
Dynamic proteomic profile, Skeletal muscle, Intra-muscular lipid profiles, Skeletal muscle glycogen, Glucose, Insulin, Leptin, Ghrelin, Testosterone, Adiponectin
Medical subject headings
Insulin Resistance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Energy BalanceDietary supplement

    Energy balance phase to elicit weight-maintenance

  • Energy DeficitDietary supplement

    Energy deficit phase to elicit weight-loss

  • Baseline AssessmentDietary supplement

    Free-living assessment of energy status

Study groups in NCT05203133
Study groupRoleWhat they receive
Baseline Assessment (Days -5 to -1)ExperimentalParticipants will complete a a 5-day baseline assessment in which habitual energy intake (remote food photography method) and exercise energy expenditure will be monitored.
Receives: Dietary Supplement: Baseline Assessment
Energy Balance (Days 1 to 5)ExperimentalParticipants will be provided with all food intake for five days, to provide an energy intake of 54 kcal/kg FFM/day. On days 1, 3 and 5, participants will complete aerobic (cycling) exercise at ~60% VO2peak to expend15 kcal/kg FFM. This will achieve a state of energy balance (energy availability = 45 kcal/kg of FFM/day, required for weight maintenance.
Receives: Dietary Supplement: Energy Balance
Energy Deficit (Days 6-11)ExperimentalParticipants will be provided with all food intake for five days, to provide an energy intake of 19 kcal/kg FFM/day. On days 6, 8 and 10, participants will complete aerobic (cycling) exercise at ~60% VO2peak to expend15 kcal/kg FFM. This will achieve a state of energy deficit (energy availability = 10 kcal/kg of FFM/day) resulting in ~2.5 kg of weight-loss.
Receives: Dietary Supplement: Energy Deficit

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Alterations to skeletal muscle proteome

    Quantification of changes in skeletal muscle quality via dynamic proteomic profiling following short-term energy balance and energy deficit.

    Measured: Days -5, 1, 6 & 11

Secondary outcomes (32)
  1. Intra-muscular lipid profile: lipid droplet content

    Assessment of alterations in intra-muscular lipid droplet content

    Measured: Days -5, 1, 6 & 11

  2. Intra-muscular lipid profile: lipid droplet morphology

    Assessment of alterations in intra-muscular lipid morphology

    Measured: Days -5, 1, 6 & 11

  3. Intra-muscular lipid profile: lipid droplet associated proteins

    Assessment of alterations in intra-muscular lipid-droplet associated proteins

    Measured: Days -5, 1, 6 & 11

  4. Blood metabolites/hormones: Glucose concentrations

    Assessment of alterations in blood metabolites and hormones following short-term energy balance and energy deficit.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  5. Blood metabolites/hormones: Insulin concentrations

    Assessment of alterations in blood metabolites and hormones following short-term energy balance and energy deficit.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  6. Blood metabolites/hormones: Leptin concentrations

    Assessment of alterations in blood metabolites and hormones following short-term energy balance and energy deficit.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  7. Blood metabolites/hormones: Ghrelin concentrations

    Assessment of alterations in blood metabolites and hormones following short-term energy balance and energy deficit.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  8. Blood metabolites/hormones: Lactate concentrations

    Assessment of alterations in blood metabolites and hormones following short-term energy balance and energy deficit.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  9. Blood metabolites/hormones: Testosterone concentrations

    Assessment of alterations in blood metabolites and hormones following short-term energy balance and energy deficit.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  10. Blood metabolites/hormones: Adiponectin concentrations

    Assessment of alterations in blood metabolites and hormones following short-term energy balance and energy deficit.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  11. Blood metabolites/hormones: Triiodothyronine concentrations

    Assessment of alterations in blood metabolites and hormones following short-term energy balance and energy deficit.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  12. Blood bone turnover markers: Beta-CTX concentrations

    Assessment of alterations in blood metabolites and hormones following short-term energy balance and energy deficit.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  13. Blood bone turnover markers: P1NP concentrations

    Assessment of alterations in blood metabolites and hormones following short-term energy balance and energy deficit.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  14. Skeletal Muscle Glycogen Concentrations

    Assessment of alterations in skeletal muscle glycogen concentrations following short-term energy balance and energy deficit.

    Measured: Days -5, 1, 6 & 11

  15. Changes in body composition: Body Mass (kg)

    Assessment of alterations in body mass and body composition following short-term energy balance and energy deficit. Assessed via bio-electrical impedance analysis.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  16. Changes in body composition: Body Mass Index [BMI] (kg/m^2)

    Assessment of alterations in body mass and body composition following short-term energy balance and energy deficit. Assessed via bio-electrical impedance analysis.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  17. Changes in body composition: Fat Mass (kg)

    Assessment of alterations in body mass and body composition following short-term energy balance and energy deficit. Assessed via bio-electrical impedance analysis.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  18. Changes in body composition: Body Fat Percentage (%)

    Assessment of alterations in body mass and body composition following short-term energy balance and energy deficit. Assessed via bio-electrical impedance analysis.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  19. Changes in body composition: Fat Free Mass (kg)

    Assessment of alterations in body mass and body composition following short-term energy balance and energy deficit. Assessed via bio-electrical impedance analysis.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  20. Changes in body composition: Skeletal Muscle Mass (kg)

    Assessment of alterations in body mass and body composition following short-term energy balance and energy deficit. Assessed via bio-electrical impedance analysis.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  21. Changes in body composition: Total Body Water (l)

    Assessment of alterations in body mass and body composition following short-term energy balance and energy deficit. Assessed via bio-electrical impedance analysis.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  22. Changes in body composition: Total Body Water (%)

    Assessment of alterations in body mass and body composition following short-term energy balance and energy deficit. Assessed via bio-electrical impedance analysis.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  23. Changes in body composition: Extracellular Water (l)

    Assessment of alterations in body mass and body composition following short-term energy balance and energy deficit. Assessed via bio-electrical impedance analysis.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  24. Changes in body composition: Extracellular Water (%)

    Assessment of alterations in body mass and body composition following short-term energy balance and energy deficit. Assessed via bio-electrical impedance analysis.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  25. Changes in body composition: Extracellular Water/Total Body Water ratio (%)

    Assessment of alterations in body mass and body composition following short-term energy balance and energy deficit. Assessed via bio-electrical impedance analysis.

    Measured: Days -5, 1, 3, 5, 6, 8, 10 & 11

  26. Changes in body composition: Body Mass (kg)

    Assessment of alterations in body mass and body composition following short-term energy balance and energy deficit. Assessed via DXA.

    Measured: Days -5, 1, 6, & 11

  27. Changes in body composition: Fat Mass (kg)

    Assessment of alterations in body mass and body composition following short-term energy balance and energy deficit. Assessed via DXA.

    Measured: Days -5, 1, 6, & 11

  28. Changes in body composition: Percent Body Fat (%)

    Assessment of alterations in body mass and body composition following short-term energy balance and energy deficit. Assessed via DXA.

    Measured: Days -5, 1, 6, & 11

  29. Changes in body composition: Bone Mineral Content (g)

    Assessment of alterations in body mass and body composition following short-term energy balance and energy deficit. Assessed via DXA.

    Measured: Days -5, 1, 6, & 11

  30. Changes in body composition: Bone Mineral Density (g/cm^2)

    Assessment of alterations in body mass and body composition following short-term energy balance and energy deficit. Assessed via DXA.

    Measured: Days -5, 1, 6, & 11

  31. Changes in body composition: Fat Free Mass (kg)

    Assessment of alterations in body mass and body composition following short-term energy balance and energy deficit. Assessed via DXA.

    Measured: Days -5, 1, 6, & 11

  32. Changes in Resting Metabolic Rate (kcal/day)

    Assessment of alterations in resting metabolic rate following short-term energy balance and energy deficit.

    Measured: Days -5, 1, & 11.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jan 2022
  2. Study start23 Aug 2021
  3. Primary completion15 Dec 2021
  4. Study completion15 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Sequential
Model description
Participants will complete a 5-day free-living baseline assessment period (days -5 to -1) and two consecutive 5-day periods (days 1 - 10, with a final assessment on the morning of day 11) of controlled exercise to increase oxidative capacity (3 days of aerobic exercise per period, 15 kcal/kg FFM/day energy expenditure cycling) and energy intake. This will achieve states of energy balance (EB; energy availability - EA - 45 kcal/kg of fat free mass (FFM)/day), required for weight maintenance (days 1 - 5), followed by energy deficit (ED; EA 10 kcal/kg FFM/day), required for weight loss on days 6 - 10.
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05203133
Sponsor's protocol ID
21LJMUSPONSOR052
Status last verified
Nov 2022
First submitted
28 Sep 2021
Last updated
9 Nov 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Areta JL, Burke LM, Camera DM, West DW, Crawshay S, Moore DR, Stellingwerff T, Phillips SM, Hawley JA, Coffey VG. Reduced resting skeletal muscle protein synthesis is rescued by resistance exercise and protein ingestion following short-term energy deficit. Am J Physiol Endocrinol Metab. 2014 Apr 15;306(8):E989-97. doi: 10.1152/ajpendo.00590.2013. Epub 2014 Mar 4.

    PubMed 24595305
  • Areta JL, Hopkins WG. Skeletal Muscle Glycogen Content at Rest and During Endurance Exercise in Humans: A Meta-Analysis. Sports Med. 2018 Sep;48(9):2091-2102. doi: 10.1007/s40279-018-0941-1.

    PubMed 29923148
  • Areta JL, Iraki J, Owens DJ, Joanisse S, Philp A, Morton JP, Hallen J. Achieving energy balance with a high-fat meal does not enhance skeletal muscle adaptation and impairs glycaemic response in a sleep-low training model. Exp Physiol. 2020 Oct;105(10):1778-1791. doi: 10.1113/EP088795. Epub 2020 Sep 7.

    PubMed 32820838
  • Civitarese AE, Carling S, Heilbronn LK, Hulver MH, Ukropcova B, Deutsch WA, Smith SR, Ravussin E; CALERIE Pennington Team. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med. 2007 Mar;4(3):e76. doi: 10.1371/journal.pmed.0040076.

    PubMed 17341128
  • Hall KD. Body fat and fat-free mass inter-relationships: Forbes's theory revisited. Br J Nutr. 2007 Jun;97(6):1059-63. doi: 10.1017/S0007114507691946. Epub 2007 Mar 19.

    PubMed 17367567
  • Hall KD, Chow CC. Estimating changes in free-living energy intake and its confidence interval. Am J Clin Nutr. 2011 Jul;94(1):66-74. doi: 10.3945/ajcn.111.014399. Epub 2011 May 11.

    PubMed 21562087
  • Hammond KM, Sale C, Fraser W, Tang J, Shepherd SO, Strauss JA, Close GL, Cocks M, Louis J, Pugh J, Stewart C, Sharples AP, Morton JP. Post-exercise carbohydrate and energy availability induce independent effects on skeletal muscle cell signalling and bone turnover: implications for training adaptation. J Physiol. 2019 Sep;597(18):4779-4796. doi: 10.1113/JP278209. Epub 2019 Aug 21.

    PubMed 31364768
  • Hawley JA, Morton JP. Ramping up the signal: promoting endurance training adaptation in skeletal muscle by nutritional manipulation. Clin Exp Pharmacol Physiol. 2014 Aug;41(8):608-13. doi: 10.1111/1440-1681.12246.

    PubMed 25142094
  • Holwerda AM, Bouwman FG, Nabben M, Wang P, van Kranenburg J, Gijsen AP, Burniston JG, Mariman ECM, van Loon LJC. Endurance-Type Exercise Increases Bulk and Individual Mitochondrial Protein Synthesis Rates in Rats. Int J Sport Nutr Exerc Metab. 2020 Mar 1;30(2):153-164. doi: 10.1123/ijsnem.2019-0281. Epub 2020 Feb 7.

    PubMed 32035417
  • Impey SG, Hearris MA, Hammond KM, Bartlett JD, Louis J, Close GL, Morton JP. Fuel for the Work Required: A Theoretical Framework for Carbohydrate Periodization and the Glycogen Threshold Hypothesis. Sports Med. 2018 May;48(5):1031-1048. doi: 10.1007/s40279-018-0867-7.

    PubMed 29453741
  • Rabol R, Svendsen PF, Skovbro M, Boushel R, Haugaard SB, Schjerling P, Schrauwen P, Hesselink MK, Nilas L, Madsbad S, Dela F. Reduced skeletal muscle mitochondrial respiration and improved glucose metabolism in nondiabetic obese women during a very low calorie dietary intervention leading to rapid weight loss. Metabolism. 2009 Aug;58(8):1145-52. doi: 10.1016/j.metabol.2009.03.014. Epub 2009 Jun 18.

    PubMed 19454354
  • Rhoads TW, Clark JP, Gustafson GE, Miller KN, Conklin MW, DeMuth TM, Berres ME, Eliceiri KW, Vaughan LK, Lary CW, Beasley TM, Colman RJ, Anderson RM. Molecular and Functional Networks Linked to Sarcopenia Prevention by Caloric Restriction in Rhesus Monkeys. Cell Syst. 2020 Feb 26;10(2):156-168.e5. doi: 10.1016/j.cels.2019.12.002. Epub 2020 Jan 22.

    PubMed 31982367
  • Smiles WJ, Areta JL, Coffey VG, Phillips SM, Moore DR, Stellingwerff T, Burke LM, Hawley JA, Camera DM. Modulation of autophagy signaling with resistance exercise and protein ingestion following short-term energy deficit. Am J Physiol Regul Integr Comp Physiol. 2015 Sep;309(5):R603-12. doi: 10.1152/ajpregu.00413.2014. Epub 2015 Jul 1.

    PubMed 26136534
  • Whytock KL, Parry SA, Turner MC, Woods RM, James LJ, Ferguson RA, Stahlman M, Boren J, Strauss JA, Cocks M, Wagenmakers AJM, Hulston CJ, Shepherd SO. A 7-day high-fat, high-calorie diet induces fibre-specific increases in intramuscular triglyceride and perilipin protein expression in human skeletal muscle. J Physiol. 2020 Mar;598(6):1151-1167. doi: 10.1113/JP279129. Epub 2020 Feb 14.

    PubMed 31958145

Questions about this trial

What is this clinical trial studying?

A study testing Energy Balance, Energy Deficit and Baseline Assessment in people with Energy Supply; Deficiency and Energy Balance, run by Liverpool John Moores University at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Alterations to skeletal muscle proteome (time frame: Days -5, 1, 6 & 11). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05203133, which also lists 14 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in